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The present study examined the relationship between tumour stage, grade, T-lymphocyte subset infiltration and survival in patients
who had undergone potentially curative surgery for renal clear-cell cancer (n¼73). Intratumoural CD4þ T-lymphocyte infiltrate was
associated with poor cancer-specific survival, independent of grade, in this cohort.
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Local and systemic inflammatory responses are regulated through
the production of proteins, such as cytokines, by immunologically
active cells. In cancer, this mechanism is disturbed by the presence
of the tumour and this dysregulation may contribute to the poorer
outcome in the cancer patient (Balkwill and Mantovani, 2001).
Recent work has suggested that the presence of specific T-
lymphocyte subsets has prognostic value in a number of solid
tumours. Naito et al (1998) demonstrated that increased numbers
of CD8þ T lymphocytes in the tumour were associated with better
survival in patients with colorectal cancer.
There has been little work carried out in renal cancer and the
results appear to be different from other solid tumours. Kolbeck
et al (1992) in a small study reported that increased tumour T-cell
infiltration was associated with increased tumour recurrence. More
recently, in a larger series, it has been reported that increased
numbers of CD8þ T lymphocytes in the tumour are associated
with poor survival in patients with renal cancer (Nakano et al,
2001).
The aim of the present study was to examine the relationship
between tumour stage, grade, T-lymphocyte subset infiltration and
survival in patients who had undergone potentially curative
surgery for renal clear-cell cancer.
PATIENTS AND METHODS
Patients
Patients with histologically proven renal clear-cell cancer that, on
the basis of preoperative CT-scan of the abdomen and chest and
pathological assessment of the resected tumour, were considered
to have undergone potentially curative surgery between July 1997
and December 2000 in the North Glasgow NHS Trust were
included in the study. Pathological staging was based on TNM and
classified as pII or 4II (Guinan et al, 1997).
The study was approved by the local ethical committee.
Immunohistochemistry
Blocks from the primary tumour were fixed in 10% buffered
formalin and embedded in paraffin wax. One representative block
of tumour was selected for each patient. Sections (4mm) were cut
and mounted on slides coated with aminopropyltriethoxysilane.
Sections were then immunostained using the peroxidase-based
Envision (Dako, Cambridgeshire, UK) technique. The primary
antibody for CD4 was mouse monoclonal (Vector, Peterborough,
UK) and that for CD8 was mouse monoclonal (Dako, Cambridge-
shire, UK). Sections were dewaxed and rehydrated. Endogenous
peroxidase was blocked by incubation in 0.3% hydrogen peroxide
for 10min. Antigen retrieval for CD8 was performed by micro-
waving in 1mM EDTA buffer, pH 8, for 5min at full pressure in
aplastic pressure cooker in a microwave oven. Antigen retrieval for
CD4 was achieved by immersing the sections in high pH buffer
(9.9, Dako) in a Coplin jar, maintained at 991C for 75min in a
water bath.
The sections were then incubated with the primary antibodies at
dilutions of 1:50 (CD4) and 1:100 (CD8) for 30min at room
temperature. Sites of binding were detected using the Envision kit
with 3030diaminobenzidine as chromogen according to the
manufacturer’s instructions. Sections were counterstained with
haematoxylin, dehydrated, cleared and mounted with Pertex.
Morphometry
Quantitative analysis of the lymphoid infiltrate was performed
using point counting (Anderson and Dunnill, 1965) with a random
sampling technique. With this method, the volume occupied by
any given component (volume density) is expressed as a
percentage of the total volume of the tissue. In the present study,
the volumes of CD4þ and CD8þ immunopositive cells were
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ycalculated as percentage of the total tumour volume. A 100-point
ocular grid was used at  400 magnification and 30 fields were
counted per case for each antibody. Only fields within the tumour
(including cancer cell nests and surrounding tissue stroma) were
counted. Any normal tissue on the slide was excluded from the
analysis.
This final method was designed on the basis of a pilot study,
which demonstrated that the volume density of CD4þ and CD8þ
of two observers reached a plateau after 25–30 fields. This pilot
study also demonstrated that CD4þ and CD8þ counts were
equivalent to the CD3þ counts (unpublished data). The observers
(KC and PAM) were blinded to the clinical outcome of the patient.
Statistics
The data are presented as median and range. Comparisons
between groups of patients were carried out using contingency
table analysis (X
2), the Mann–Whitney U-test or Kaplan–Meier
analysis as appropriate.
Survival analysis was performed using the Cox proportional
hazard model with patients’ age, sex, TNM stage, CD4þ and
CD8þ count as prognostic variables. Deaths up to September 2002
have been included in the analysis. Multivariate survival analysis
was performed using a stepwise backward procedure to derive a
final model of the variables that had a significant independent
relationship with survival. To remove a variable from the model,
the corresponding P-value had to be greater than 0.10. Analysis
was performed using SPSS software (SPSS Inc., Chicago, IL, USA).
RESULTS
Baseline characteristics of the patients (n¼73) who underwent
curative surgery for renal cell cancer are shown in Table 1. The
majority of patients was male, had stage I/ II disease and had grade
II/ III tumours. Compared with patients of stage oII disease,
tumours were of higher grade (Po0.01), greater volume (Po0.01)
and increased CD4þ T-lymphocytic infiltration (Po0.05) in
patients with stage 4II disease. This was also associated with
poorer cancer-specific survival (Po0.01).
No patients received additional therapy in the immediate
postoperative period. A total of 17 patients developed recurrence
and all received alpha-interferon based immunotherapy.
On univariate analysis, TNM stage (Po0.01), grade (Po0.001)
and CD4þ count (Po0.001) were associated with cancer-specific
survival (Table 2). On multivariate analysis, grade (HR 2.47, 95%
CI 1.37–4.46, Po0.01) and percentage CD4þ (HR 4.44, 95% CI
1.87–10.57, Po0.001) were independently associated with cancer-
specific survival.
DISCUSSION
The results of the present study show that an increase in CD4þ
but not CD8þ T-lymphocyte infiltrate, as assessed by immuno-
histochemistry, was associated with poor cancer-specific survival,
independent of grade, in patients undergoing potentially curative
surgery for renal clear-cell cancer. Few studies have examined the
relationship between tumour T-lymphocyte infiltrate and outcome
in patients with renal cancer. Kolbeck et al (1992) reported that, in
a small study of 24 cases, increased tumour T-cell infiltration was
associated with increased tumour recurrence. Nakano et al (2001)
reported that a high tumour CD8þ T-lymphocyte infiltrate was
associated with poorer survival independent of grade. In contrast,
in the present study, there was no relationship between tumour
CD8þ T-lymphocyte infiltrate and cancer-specific survival. This
discrepancy may be related to the larger number of cases in their
study. Alternatively, it may be due to methodological differences in
the way in which the T-cell infiltrate was calculated. The sampling
in the present study was much greater and was designed to
circumvent the problem of variation in distribution of lympho-
cytes within an individual tumour. Nakano et al (2001) did not
specifically quantify intratumoural CD4þ lymphocytes and
therefore direct comparison with the present study may be
inappropriate. However, they performed a semiquantitative
analysis of CD4þ and CD8þ lymphocytes at the periphery of
the tumours and found that higher levels of infiltration of both
were associated with reduced survival. We have not looked
specifically in this area.
The findings of the present and previous studies would suggest
that a conspicuous tumour T-lymphocyte infiltrate, in particular
CD4þ, was associated with poor cancer survival in patients with
renal cell cancer. However, it is not clear whether the infiltration of
CD4þ T-lymphocytes within the tumour is a sign of an active
immune response or whether it is a more passive consequence of
cytokine excretion from the tumour that attracts T lymphocytes.
Given that renal cancer is recognised to be immunogenic in nature
and that it responds to immunomodulatory therapy, it may
be speculated that the immune response in renal cancer is an active,
perhaps antigen driven, process (Michael and Pandha, 2003).
Table 1 Baseline characteristics, according to stage, of patients who
underwent curative surgery for renal cancer
TNM stage pII TNM stage 4II
(n¼40) (n¼33) P-value
Age group
p60 22 14
460 18 19 0.285
Sex
Male 26 23
Female 14 10 0.671
Grade Furhman
I1 0 2
II 20 10
III 7 13
IV 3 8 0.007
Tumour volume (cm
3) 69 (1–3040) 224 (21–729) 0.003
% tumour volume
CD4+
a 0.40 (0.07–1.63) 0.70 (0.13–2.10) 0.046
CD8+
a 1.08 (0.03–6.13) 0.97 (0.20–9.40) 0.833
CD4+ plus CD8+
a 1.40 (0.10–6.73) 1.67 (0.40–11.4) 0.303
Alive 33 18
Dead (cancer specific/
noncancer)
4/3 13/2 0.012
Median survival
(months)
29.1 (15.4–35.6) 19.2 (2.1–28.1) 0.002
aMedian (range).
Table 2 Univariate analyses of the relationship between variables and
cancer-specific survival in renal cancer patients following curative resection
Variable Hazard ratio (95% CI) P-value
Age (p60/460 years) 0.939
Sex (male/female) 0.177
TNM stage (pII/4II) 5.05 (1.64–15.52) 0.005
Grade (Fuhrman I/II/III/IV) 2.60 (1.48–4.56) o0.001
Tumour volume (cm
3) 0.885
% tumour volume
CD4+ 4.96 (2.13–11.55) o0.001
CD8+ 0.405
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yIn summary, we have shown that increased intratumoural
CD4þ T-lymphocyte infiltrate was associated with poor outcome,
independent of grade, in patients with renal clear-cell cancer.
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